Molecules (Basel, Switzerland) 23 , 47 (2017)
Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia
If patients using semaglutide experience a sudden loss of vision or a rapid deterioration in eyesight, they should promptly contact their doctor
Remembering a once-weekly injection is one thing, but the set it and forget it nature of a patch (whether its a daily or a multi-day formulation) fits more seamlessly into a grueling road warrior hustle or a chaotic family schedule
doi: 10.1111/dom.13955 102 MarguliesKBHernandezAFRedfieldMMGivertzMMOliveiraGHColeRet al
For SLU-PP-332 injection, rigorous endotoxin testing is essential to ensure patient safety